{"uri": "eng-9409903", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Hypertension", "type": "wiki", "score": 100, "label": {"eng": "Hypertension"}}, {"uri": "http://en.wikipedia.org/wiki/Antihypertensive_drug", "type": "wiki", "score": 97, "label": {"eng": "Antihypertensive drug"}}, {"uri": "http://en.wikipedia.org/wiki/Food_and_Drug_Administration", "type": "wiki", "score": 95, "label": {"eng": "Food and Drug Administration"}}, {"uri": "http://en.wikipedia.org/wiki/Blood_pressure", "type": "wiki", "score": 89, "label": {"eng": "Blood pressure"}}, {"uri": "http://en.wikipedia.org/wiki/Endothelin_receptor_antagonist", "type": "wiki", "score": 78, "label": {"eng": "Endothelin receptor antagonist"}}, {"uri": "http://en.wikipedia.org/wiki/Medication", "type": "wiki", "score": 74, "label": {"eng": "Medication"}}, {"uri": "http://en.wikipedia.org/wiki/Placebo", "type": "wiki", "score": 73, "label": {"eng": "Placebo"}}, {"uri": "http://en.wikipedia.org/wiki/Endothelin", "type": "wiki", "score": 67, "label": {"eng": "Endothelin"}}, {"uri": "http://en.wikipedia.org/wiki/Efficacy", "type": "wiki", "score": 65, "label": {"eng": "Efficacy"}}, {"uri": "http://en.wikipedia.org/wiki/Idorsia", "type": "wiki", "score": 63, "label": {"eng": "Idorsia"}}, {"uri": "http://en.wikipedia.org/wiki/Edema", "type": "wiki", "score": 55, "label": {"eng": "Edema"}}, {"uri": "http://en.wikipedia.org/wiki/Physician", "type": "wiki", "score": 54, "label": {"eng": "Physician"}}, {"uri": "http://en.wikipedia.org/wiki/Stroke", "type": "wiki", "score": 53, "label": {"eng": "Stroke"}}, {"uri": "http://en.wikipedia.org/wiki/Diuretic", "type": "wiki", "score": 52, "label": {"eng": "Diuretic"}}, {"uri": "http://en.wikipedia.org/wiki/Doctor_of_Medicine", "type": "wiki", "score": 50, "label": {"eng": "Doctor of Medicine"}}, {"uri": "http://en.wikipedia.org/wiki/Glomerular_filtration_rate", "type": "wiki", "score": 49, "label": {"eng": "Glomerular filtration rate"}}, {"uri": "http://en.wikipedia.org/wiki/Calcium_channel_blocker", "type": "wiki", "score": 49, "label": {"eng": "Calcium channel blocker"}}, {"uri": "http://en.wikipedia.org/wiki/Side_effect", "type": "wiki", "score": 46, "label": {"eng": "Side effect"}}, {"uri": "http://en.wikipedia.org/wiki/Cardiovascular_disease", "type": "wiki", "score": 46, "label": {"eng": "Cardiovascular disease"}}, {"uri": "http://en.wikipedia.org/wiki/Beta_blocker", "type": "wiki", "score": 44, "label": {"eng": "Beta blocker"}}, {"uri": "http://en.wikipedia.org/wiki/United_States", "type": "loc", "score": 11, "label": {"eng": "United States"}, "location": {"type": "country", "label": {"eng": "United States"}}}, {"uri": "http://en.wikipedia.org/wiki/Europe", "type": "loc", "score": 9, "label": {"eng": "Europe"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/North_America", "type": "loc", "score": 9, "label": {"eng": "North America"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/Brooklyn", "type": "loc", "score": 9, "label": {"eng": "Brooklyn"}, "location": {"type": "place", "label": {"eng": "Brooklyn"}, "country": {"type": "country", "label": {"eng": "United States"}}}}, {"uri": "http://en.wikipedia.org/wiki/Philadelphia", "type": "loc", "score": 9, "label": {"eng": "Philadelphia"}, "location": {"type": "place", "label": {"eng": "Philadelphia"}, "country": {"type": "country", "label": {"eng": "United States"}}}}, {"uri": "http://en.wikipedia.org/wiki/Basel", "type": "loc", "score": 9, "label": {"eng": "Basel"}, "location": {"type": "place", "label": {"eng": "Basel"}, "country": {"type": "country", "label": {"eng": "Switzerland"}}}}, {"uri": "http://en.wikipedia.org/wiki/Australia", "type": "loc", "score": 9, "label": {"eng": "Australia"}, "location": {"type": "country", "label": {"eng": "Australia"}}}, {"uri": "http://en.wikipedia.org/wiki/University_of_Sydney", "type": "org", "score": 7, "label": {"eng": "University of Sydney"}}, {"uri": "http://en.wikipedia.org/wiki/Allschwil", "type": "loc", "score": 6, "label": {"eng": "Allschwil"}, "location": {"type": "place", "label": {"eng": "Allschwil"}, "country": {"type": "country", "label": {"eng": "Switzerland"}}}}], "eventDate": "2024-03-20", "totalArticleCount": 14, "title": {"eng": "FDA Okays New Drug for Resistant Hypertension"}, "summary": {"eng": "The US Food and Drug Administration (FDA) has approved aprocitentan (Tryvio) to lower blood pressure, in combination with other antihypertensive agents, in adults with treatment-resistant hypertension.\n\nAprocitentan is the first endothelin receptor antagonist approved for patients with hypertension. The recommended dose is 12.5 mg orally once daily, with or without food.\n\nThe efficacy and safety of aprocitentan were demonstrated in the phase 3 PRECISION study of 730 adults with systolic blood pre"}, "location": {"type": "place", "label": {"eng": "Basel"}, "country": {"type": "country", "label": {"eng": "Switzerland"}}}, "categories": [{"uri": "dmoz/Health/Pharmacy/Drugs_and_Medications", "label": "dmoz/Health/Pharmacy/Drugs and Medications", "wgt": 77}, {"uri": "dmoz/Health/Teen_Health/Drugs_and_Alcohol", "label": "dmoz/Health/Teen Health/Drugs and Alcohol", "wgt": 89}, {"uri": "dmoz/Health/Men's_Health/Conditions_and_Diseases", "label": "dmoz/Health/Men's Health/Conditions and Diseases", "wgt": 100}, {"uri": "news/Health", "label": "news/Health", "wgt": 82}], "articleCounts": {"eng": 14}, "sentiment": 0.05882352941176472, "wgt": 448588800, "relevance": 2}